| Dr Ahmed R Nizar, MD | |
|
742 James St, Outpatient Mental Health Services, Syracuse, NY 13203-2017 | |
| (315) 703-2700 | |
| (315) 703-2700 |
| Full Name | Dr Ahmed R Nizar |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 29 Years |
| Location | 742 James St, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063590115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | 002475-1 (New York) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 259983 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital Health Center | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Josephs Hospital Health Center | 9234043324 | 82 |
| Psychiatry Faculty Practice, Inc | 9234458530 | 63 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
| Entity Name | Claxton-hepburn Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891753034 PECOS PAC ID: 8426966508 Enrollment ID: O20031110000552 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
| Entity Name | St Josephs Hospital Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508815333 PECOS PAC ID: 9234043324 Enrollment ID: O20031113000400 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
| Entity Name | Upstate Community Medical, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689620163 PECOS PAC ID: 0143238782 Enrollment ID: O20060323000644 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
| Entity Name | Psychiatry Faculty Practice, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881084820 PECOS PAC ID: 9234458530 Enrollment ID: O20150508000699 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ahmed R Nizar, MD 742 James St, Outpatient Mental Health Services, Syracuse, NY 13203-2017 Ph: (315) 703-2700 | Dr Ahmed R Nizar, MD 742 James St, Outpatient Mental Health Services, Syracuse, NY 13203-2017 Ph: (315) 703-2700 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.
How well a person with type 2 diabetes responds to a diabetes drug may well depend upon his or her genetic make-up, according to a study published in the May issue of Diabetes Care. The study found that people who carried certain genotypes responded less favorably to rosiglitazone, a drug often prescribed for people with diabetes, than carriers of other genotypes.
A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research milestone by successfully measuring human brain activity. Experiments reported this week verify the sensor's potential for biomedical applications such as studying mental processes and advancing the understanding of neurological diseases.
In a Journal of the American Geriatrics Society study, many well-functioning and highly active older adults experienced back pain, which was linked with poorer perceived and observed walking endurance.
› Verified 1 days ago
Mantosh J Dewan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-3105 Fax: 315-464-3163 | |
Deborah Y Bradshaw, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 90 Presidential Plz, 4th Floor, Syracuse, NY 13202 Phone: 315-464-4243 Fax: 315-464-5359 | |
Dr. Haizhu Pearl Liu, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 620 Madison St, Syracuse, NY 13210 Phone: 315-426-3600 | |
Anwarul Karim, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 635 James St, Syracuse, NY 13203 Phone: 315-671-2963 Fax: 315-422-0948 | |
Sarah Rosner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 Prospect Ave, Cpep, Syracuse, NY 13203 Phone: 315-726-8610 Fax: 315-726-8667 | |
Wilbur Theodore Albrecht Iii, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 620 Madison St, Hutchings Psychiatric Center, Syracuse, NY 13210 Phone: 315-426-3600 Fax: 315-426-7641 | |
Dr. Clarence G. White, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 301 Prospect Ave, Cpep, Syracuse, NY 13203 Phone: 315-726-8610 Fax: 315-726-8667 |